BioXcel Therapeutics BTAIQ
OTC BTAIQ
$0.05 +0.00 (+0.00%)
At close: Sep 30, 2026 · 4:00 PM EDT

BioXcel Therapeutics (BTAIQ) Interest Expenses (2019 - 2026)

Updated

BioXcel Therapeutics (BTAIQ) posted Interest Expenses of $4.26 million for Q2 2026, up 0.8% from $4.22 million a year earlier and up 1.4% from the prior quarter.

Analysis

BioXcel Therapeutics (BTAIQ) Interest Expenses (2019 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Interest Expenses at BioXcel Therapeutics was $17.22 million, up 7.4% year-over-year; for FY2025, it came in at $16.98 million, up 12.3% from FY2024.

  • Annual Interest Expenses has increased for three consecutive years, with a five-year compound annual growth rate of 262.9% (FY2020 to FY2025).
  • In prior years, BioXcel Therapeutics' Interest Expenses was $15.13 million in FY2024 (+13.6%), $13.31 million in FY2023 (+62.1%), $8.21 million in FY2022 and $40,000 in FY2021 (+48.1%).
  • Quarterly Interest Expenses has run from a low of $6,000 in Q4 2021 to a high of $4.4 million in Q4 2025 over five years.
  • On a year-over-year basis, Interest Expenses has increased in each of the last 11 quarters, with growth averaging 11.1% over the last eight quarters.
  • The strongest year-over-year quarter for Interest Expenses in the past five years was Q3 2021, with growth of 120.0%; the weakest was Q3 2023, with a decline of 12.1%.
  • According to Business Quant data, Interest Expenses for the three prior quarters was $4.2 million (Q1 2026), $4.4 million (Q4 2025) and $4.37 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 BioXcel Therapeutics 1.57 Mn 1.57 Mn 160,000.00 4.26 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.26 Mn
Mar 31, 2026 4.20 Mn
Dec 31, 2025 4.40 Mn
Sep 30, 2025 4.37 Mn
Jun 30, 2025 4.22 Mn
Mar 31, 2025 3.99 Mn
Dec 31, 2024 4.03 Mn
Sep 30, 2024 3.79 Mn
Jun 30, 2024 3.70 Mn
Mar 31, 2024 3.61 Mn
Dec 31, 2023 3.44 Mn
Sep 30, 2023 3.25 Mn
Jun 30, 2023 3.26 Mn
Mar 31, 2023 3.37 Mn
Dec 31, 2022 2.92 Mn
Sep 30, 2022 3.70 Mn
Jun 30, 2022 1.59 Mn
Mar 31, 2022 7,000.00
Dec 31, 2021 6,000.00
Sep 30, 2021 11,000.00
API Access

BioXcel Therapeutics Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=BTAIQ&period=max&api_key=YOUR_API_KEY